LENZ Therapeutics, Inc. stock is traded on the Nasdaq Stock Market under the ticker symbol LENZ. LENZ Therapeutics, Inc. is in the Biotechnology & Medical Research industry.
LENZ Therapeutics, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing the first aceclidine-based eye drop to improve vision in patients diagnosed with presbyopia. Its product candidates, LNZ100 and LNZ101, are preservative-free, single-use, once-daily eye drops containing aceclidine and aceclidine plus brimonidine, respectively. LNZ100 and LNZ101 are under clinical evaluation in the registration-enabling Phase III CLARITY trials as potential therapies for the treatment of presbyopia, a condition impacting an estimated 1.8 billion people globally and 128 million people in the United States.
Stock Ticker Symbol Lookup
Here you can look up another stock ticker symbol.
Stock Ticker Symbol CRML
Here is another stock ticker symbol that we have information about!
Contact | Disclaimer | Copyright | Privacy